Is the pentavalent rotavirus vaccine administered orally or by injection?
Generally, the pentavalent rotavirus vaccine refers to the pentavalent reassortant rotavirus attenuated live vaccine, which is an oral vaccine. The details are as follows:
The pentavalent reassortant rotavirus attenuated live vaccine is for oral use only and must not be administered by injection. A complete immunization course consists of three doses. The first dose should be given orally when the infant is between 6 and 12 weeks of age, with an interval of 4 to 10 weeks between each dose. The third dose should not be administered after 32 weeks of age. After vaccination, adverse reactions such as fever, diarrhea, and vomiting may occur. This vaccine is contraindicated in individuals with known allergies to the vaccine or any of its components, those with a history of intussusception, and infants younger than 6 weeks or older than 32 weeks of age, to avoid potential health risks.
After taking the vaccine orally, it is important to get adequate rest, avoid strenuous exercise, and prevent excessive fatigue. Additionally, maintain a light diet and keep the injection site clean to prevent infection.